GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » ROE %

Curiox Biosystems Co (XKRX:445680) ROE % : 14.10% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Curiox Biosystems Co's annualized net income for the quarter that ended in Dec. 2024 was ₩6,647 Mil. Curiox Biosystems Co's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was ₩47,143 Mil. Therefore, Curiox Biosystems Co's annualized ROE % for the quarter that ended in Dec. 2024 was 14.10%.

The historical rank and industry rank for Curiox Biosystems Co's ROE % or its related term are showing as below:

XKRX:445680' s ROE % Range Over the Past 10 Years
Min: -127.09   Med: -25.33   Max: -12.12
Current: -16.39

During the past 6 years, Curiox Biosystems Co's highest ROE % was -12.12%. The lowest was -127.09%. And the median was -25.33%.

XKRX:445680's ROE % is ranked worse than
65.92% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs XKRX:445680: -16.39

Curiox Biosystems Co ROE % Historical Data

The historical data trend for Curiox Biosystems Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co ROE % Chart

Curiox Biosystems Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial -29.89 -127.09 -46.50 -20.76 -15.94

Curiox Biosystems Co Quarterly Data
Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -19.35 -20.50 -24.70 -34.03 14.10

Competitive Comparison of Curiox Biosystems Co's ROE %

For the Medical Devices subindustry, Curiox Biosystems Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curiox Biosystems Co's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Curiox Biosystems Co's ROE % distribution charts can be found below:

* The bar in red indicates where Curiox Biosystems Co's ROE % falls into.


;
;

Curiox Biosystems Co ROE % Calculation

Curiox Biosystems Co's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=-8089.025/( (52878.526+48632.419)/ 2 )
=-8089.025/50755.4725
=-15.94 %

Curiox Biosystems Co's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Sep. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=6646.52/( (45652.608+48632.419)/ 2 )
=6646.52/47142.5135
=14.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


Curiox Biosystems Co  (XKRX:445680) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=6646.52/47142.5135
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(6646.52 / 3823.848)*(3823.848 / 71398.786)*(71398.786 / 47142.5135)
=Net Margin %*Asset Turnover*Equity Multiplier
=173.82 %*0.0536*1.5145
=ROA %*Equity Multiplier
=9.32 %*1.5145
=14.10 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=6646.52/47142.5135
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (6646.52 / 6768.868) * (6768.868 / -14514.848) * (-14514.848 / 3823.848) * (3823.848 / 71398.786) * (71398.786 / 47142.5135)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9819 * -0.4663 * -379.59 % * 0.0536 * 1.5145
=14.10 %

Note: The net income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Curiox Biosystems Co ROE % Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curiox Biosystems Co Business Description

Traded in Other Exchanges
N/A
Address
Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511
Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines